The food contaminant, deoxynivalenol, modulates the Thelper/Treg balance and increases inflammatory bowel diseases

[1]  J. Cravedi,et al.  Dietary exposure to mycotoxins in the French infant total diet study. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[2]  I. Oswald,et al.  Reduced toxicity of 3-epi-deoxynivalenol and de-epoxy-deoxynivalenol through deoxynivalenol bacterial biotransformation: In vivo analysis in piglets. , 2020, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[3]  I. Oswald,et al.  Deepoxy-deoxynivalenol retains some immune-modulatory properties of the parent molecule deoxynivalenol in piglets , 2018, Archives of Toxicology.

[4]  R. Price,et al.  An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[5]  M. Djouina,et al.  Chronic ingestion of deoxynivalenol at human dietary levels impairs intestinal homeostasis and gut microbiota in mice , 2018, Archives of Toxicology.

[6]  P. Munkholm,et al.  The Natural History of IBD: Lessons Learned , 2018, Current Treatment Options in Gastroenterology.

[7]  A. Gasbarrini,et al.  Proteobacteria: A Common Factor in Human Diseases , 2017, BioMed research international.

[8]  I. Oswald,et al.  Intestinal toxicity of deoxynivalenol is limited by Lactobacillus rhamnosus RC007 in pig jejunum explants , 2017, Archives of Toxicology.

[9]  H. Ikeuchi,et al.  CD103+ Dendritic Cell Function Is Altered in the Colons of Patients with Ulcerative Colitis , 2017, Inflammatory bowel diseases.

[10]  Heather M. Wallace,et al.  Risks to human and animal health related to the presence of deoxynivalenol and its acetylated and modified forms in food and feed , 2017, EFSA journal. European Food Safety Authority.

[11]  V. Théodorou,et al.  Impact of mycotoxins on the intestine: are mucus and microbiota new targets? , 2017, Journal of toxicology and environmental health. Part B, Critical reviews.

[12]  M. Marzorati,et al.  Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation , 2017, Gut.

[13]  U. Dobrindt,et al.  The Food Contaminant Deoxynivalenol Exacerbates the Genotoxicity of Gut Microbiota , 2017, mBio.

[14]  T. Chou,et al.  Co-exposure to low doses of the food contaminants deoxynivalenol and nivalenol has a synergistic inflammatory effect on intestinal explants , 2016, Archives of Toxicology.

[15]  I. Oswald,et al.  Toxicology of deoxynivalenol and its acetylated and modified forms , 2016, Archives of Toxicology.

[16]  Y. Lippi,et al.  Microbial biotransformation of DON: molecular basis for reduced toxicity , 2016, Scientific Reports.

[17]  B. Foligné,et al.  Does oral exposure to cadmium and lead mediate susceptibility to colitis? The dark-and-bright sides of heavy metals in gut ecology , 2016, Scientific Reports.

[18]  Omry Koren,et al.  Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome , 2015, Nature.

[19]  L. Franchi,et al.  Role of Inflammasomes in Intestinal Inflammation and Crohn's Disease , 2015, Inflammatory bowel diseases.

[20]  V. Dohnal,et al.  Deoxynivalenol: signaling pathways and human exposure risk assessment—an update , 2014, Archives of Toxicology.

[21]  Kaichun Wu,et al.  Preventive effects of Escherichia coli strain Nissle 1917 with different courses and different doses on intestinal inflammation in murine model of colitis , 2014, Inflammation Research.

[22]  J. Garssen,et al.  Deoxynivalenol: a trigger for intestinal integrity breakdown , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  I. Oswald,et al.  Effect of Deoxynivalenol and Other Type B Trichothecenes on the Intestine: A Review , 2014, Toxins.

[24]  Yong-yu Li,et al.  Inflammatory bowel disease: pathogenesis. , 2014, World journal of gastroenterology.

[25]  F. Grosjean,et al.  The food contaminant deoxynivalenol activates the mitogen activated protein kinases in the intestine: interest of ex vivo models as an alternative to in vivo experiments. , 2013, Toxicon : official journal of the International Society on Toxinology.

[26]  I. Oswald,et al.  Deoxynivalenol as a New Factor in the Persistence of Intestinal Inflammatory Diseases: An Emerging Hypothesis through Possible Modulation of Th17-Mediated Response , 2013, PloS one.

[27]  F. Grosjean,et al.  Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junction proteins, and mitogen-activated protein kinases. , 2012, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  R. Giannella,et al.  Th17 cells: interactions with predisposing factors in the immunopathogenesis of inflammatory bowel disease , 2012, Expert Review of Clinical Immunology.

[29]  B. Chassaing,et al.  The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. , 2011, Gastroenterology.

[30]  J. Fantini,et al.  Some food-associated mycotoxins as potential risk factors in humans predisposed to chronic intestinal inflammatory diseases. , 2010, Toxicon : official journal of the International Society on Toxinology.

[31]  J. Pestka.  Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance , 2010, Archives of Toxicology.

[32]  C. Wild,et al.  Urinary Deoxynivalenol Is Correlated with Cereal Intake in Individuals from the United Kingdom , 2007, Environmental health perspectives.

[33]  Y. Ishii,et al.  Human thioredoxin-1 ameliorates experimental murine colitis in association with suppressed macrophage inhibitory factor production. , 2006, Gastroenterology.

[34]  Robert M Eppley,et al.  Characterization of the effect of deoxynivalenol on selected male reproductive endpoints. , 2005, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[35]  H. Tilg,et al.  Imbalance between interleukin‐1 agonists and antagonists: relationship to severity of inflammatory bowel disease , 2004, Clinical and experimental immunology.

[36]  J. Larsen,et al.  Workshop on trichothecenes with a focus on DON: summary report. , 2004, Toxicology letters.

[37]  J. Schölmerich,et al.  Preventive Effects of Escherichia coli Strain Nissle 1917 on Acute and Chronic Intestinal Inflammation in Two Different Murine Models of Colitis , 2004, Clinical Diagnostic Laboratory Immunology.

[38]  M. Büchler,et al.  Characterisation of Acute Murine Dextran Sodium Sulphate Colitis: Cytokine Profile and Dose Dependency , 2000, Digestion.

[39]  J. Ni,et al.  Effects of dextran sulphate sodium on intestinal epithelial cells and intestinal lymphocytes. , 1996, Gut.

[40]  R. Macdermott,et al.  Enhand secretion of tumour necrosis factor‐alpha, IL‐6, and IL‐1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease , 1993 .

[41]  H. Lochs,et al.  Intestinal permeability and the prediction of relapse in Crohri's disease , 1993, The Lancet.

[42]  M. Bickis,et al.  The toxicity of orally administered deoxynivalenol (vomitoxin) in rats and mice. , 1986, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[43]  R. Vesonder,et al.  Subchronic toxicity of vomitoxin in Sprague-Dawley rats. , 1985, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[44]  D. Iliopoulos,et al.  Environmental triggers in IBD: a review of progress and evidence , 2018, Nature Reviews Gastroenterology & Hepatology.

[45]  S. Ng,et al.  Understanding and Preventing the Global Increase of Inflammatory Bowel Disease. , 2017, Gastroenterology.

[46]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[47]  B. Becher,et al.  RORgamma-expressing Th17 cells induce murine chronic intestinal inflammation via redundant effects of IL-17A and IL-17F. , 2009, Gastroenterology.

[48]  M. Pieters,et al.  Risk assessment of deoxynivalenol in food: concentration limits, exposure and effects. , 2002, Advances in experimental medicine and biology.

[49]  S. Schreiber,et al.  Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. , 1993, Clinical and experimental immunology.